Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck Sharpe & Dohme
Pharma
Merck challenges Johns Hopkins University's Keytruda patents
The company claims the research university breached its contract relating to a joint trial the two ran in 2013 and wrongfully secured Keytruda patents.
Zoey Becker
Mar 14, 2024 7:30am
Lousy basal insulin market prompts Merck to ditch Lantus biosim
Oct 12, 2018 11:03am
NICE gives Merck thumbs-down on Keytruda in lymphoma
Sep 4, 2018 11:36am
FiercePharmaAsia—Gardasil, Lupin, CANbridge and more
May 26, 2017 9:11am
Merck has high Keytruda hopes outside U.S., but Q1 details sparse
May 9, 2016 5:07am
